Recent developments highlight Centrus Energy's operational progress in uranium enrichment expansion, financial performance in Q3 2026, and strategic investments in manufacturing capacity.

• Centrus Energy's Q3 2026 earnings call emphasized progress in enrichment expansion and delivery of HALEU to the DOE [N1].
• The company reported Q3 earnings with gains from warrants despite a decline in sales [N2].
• Centrus Energy beat Q3 earnings and revenue expectations, reflecting operational strength [N4].
• Key Q3 metrics were compared to market expectations, showing solid performance [N5].
• Centrus invested $116 million on a supplier with oil and gas customers to support nuclear-related operations [N6].
• Plans for uranium enrichment capacity expansion in Piketon, Ohio, continue with design and manufacturing activities underway [N1][N7].

Centrus Energy benefits from increasing demand for carbon-free nuclear power and the critical need for HALEU in next-generation reactors. Its exclusive NRC license for HALEU enrichment and ongoing expansion of enrichment capacity position it to capture significant market share. Government contracts and funding support provide financial backing for growth initiatives. The company's backlog of $2.3 billion in LEU sales contracts and investments in manufacturing infrastructure underpin potential operational scale and revenue diversification.

Centrus faces risks related to supply chain disruptions that could impact its ability to fulfill customer orders. The timing and scale of uranium enrichment expansion depend on securing continued public and private funding, which is uncertain. Contract awards from the DOE are subject to negotiation and may not materialize as anticipated. Market price volatility for uranium and enrichment services, regulatory changes, and geopolitical factors such as import bans and international agreements could adversely affect operations and margins.

Centrus Energy's moat is anchored in its unique position as the sole U.S. company licensed and operationally capable of producing HALEU, a critical fuel component for advanced nuclear reactors. Its long-term contracts with major utilities through 2040 and strategic partnerships with the U.S. Department of Energy provide a stable revenue base and significant barriers to entry. The company's investments in advanced centrifuge manufacturing and uranium enrichment infrastructure further strengthen its competitive advantage by enabling scale and technological leadership in a highly specialized and regulated market.

• Supply Chain Disruptions: Disruptions in supply chains may impact Centrus's ability to fill existing customer orders, affecting revenue and customer relationships [S1].
• Funding and Contract Uncertainty: Expansion plans for uranium enrichment capacity depend on obtaining public and private funding and successful negotiation of DOE contracts, which are not guaranteed [S1].
• Market and Regulatory Risks: Market price volatility for uranium and enrichment services, regulatory changes, and geopolitical factors such as import bans and international agreements could negatively impact business operations and profitability [S1].

• Centrus Energy Corp. is a Delaware corporation supplying nuclear fuel components for the nuclear power industry, focusing on carbon-free energy and enrichment and technical services for public and private customers [S1].
• The company operates two business segments: LEU (Low Enriched Uranium) supplying nuclear fuel components primarily to utilities operating commercial nuclear power plants, and Technical Solutions providing advanced uranium enrichment including HALEU production and technical services to government and private sector customers [S1].
• LEU segment generates most of the company's revenue and involves sales of LEU, enrichment measured in SWU, natural uranium hexafluoride, and occasionally uranium concentrates and conversion services [S1].
• LEU segment backlog includes medium and long-term sales contracts and contingent sales commitments with major utilities through 2040, supported by cost-competitive SWU supply contracts [S1].
• Technical Solutions segment operates uranium enrichment capacity for HALEU production under DOE contracts, focusing on advanced nuclear fuel for existing and next-generation reactors [S1].
• Centrus is the only company with NRC license actively enriching HALEU (5%-20% U-235 concentration) and operates a small-scale HALEU production facility, delivering first HALEU to DOE in November 2023 [S1].
• HALEU production is critical for advanced reactors, with Centrus positioned to fill supply chain gaps for next-generation nuclear fuels [S1].
• The company announced plans in September 2025 for major expansion of uranium enrichment capacity in Piketon, Ohio, including large-scale LEU and HALEU production, with design work and centrifuge manufacturing initiated in late 2025 [S1].
• DOE has awarded multiple contracts and task orders to Centrus for HALEU production, deconversion, and LEU production, with contract values and funding subject to negotiation and task order issuance [S1].
• Centrus is investing over $560 million to transition its Oak Ridge facility to high-rate centrifuge manufacturing, supporting production of advanced centrifuges expected to come online in 2029 [S1].
• The company reported cash and equivalents of $2.236 billion and current assets of $2.485 billion against current liabilities of $288.7 million as of September 30, 2026, resulting in a current ratio of 8.61 and cash ratio of 7.75 [S2].
• Net income for Q3 2026 was $31.6 million with basic EPS of $1.53 and diluted EPS of $1.41 as of September 30, 2026 [S2].
• Recent news highlights include Q3 2026 earnings call emphasizing enrichment expansion progress, earnings beat on warrant gain despite sales decline, and ongoing efforts to expand uranium enrichment capacity [N1][N2][N3][N4][N5][N6].
• Centrus has a backlog of $2.3 billion in contingent LEU sales to U.S. and international customers [S1].
• The company is leveraging clean energy tax credits and government funding programs to support manufacturing and enrichment expansion [S1].